Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Clovis Oncology Inc. buy DomRuinart

Clovis Oncology Inc.

Start price

€3.55

/ 50%

Target price

13.10.19

Performance (%)

End price

€2.98

Summary

This prediction ended on with a price of €2.98. The price of Clovis Oncology Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of . DomRuinart has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y	3y
Clovis Oncology Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by DomRuinart for this prediction

In the thread Clovis Oncology Inc. diskutieren

Prediction Buy

Perf. (%)

Target price 5.000

Change

Ends at

Buy mit Kursziel 5,0

0

Meiner Ansicht nach braucht NOVARTIS einen PARP inhibitor für eine Combi-Therapie mit ihrem FLT 3 inhibitor Midostaurin. Eine Partnerschaft mit Clovis würde hier schon Sinn ergeben...oder aber die kaufen gleich den ganzen Laden und haben dann mit Rubraca ihren eigenen vielversprechenden PARP inhibitor...würde mich bei dem Kurs nicht überraschen...

0

Prediction Buy

Perf. (%)

Target price 5.000

Change

Ends at

Buy beendet

0

Stopped prediction by DomRuinart for Clovis Oncology Inc.

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€4.31

07.09.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€4.39

23.08.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€5.45

10.08.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€5.64

03.08.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€6.35

13.07.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€5.93

28.06.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€6.51

14.06.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€9.48

02.06.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€7.20

18.05.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€7.62

04.05.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€5.95

20.04.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€4.11

06.04.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€6.75

22.03.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€9.89

08.03.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€8.71

24.02.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€7.78

09.02.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€8.41

26.01.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€10.12

12.01.20

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€8.89

22.12.19

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€8.00

07.12.19

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€5.60

24.11.19

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€2.76

10.11.19

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€2.97

28.10.19

50%

Clovis Oncology Inc.

Start price

Target price

Perf. (%)

€23.80

30.09.19

50%